BRASILIA (Reuters) – The Brazilian pharmaceutical company that will make Russia’s Sputnik V vaccine against COVID-19 expects regulatory approval for Phase III tests by this week or early next ...

Batches of Russia’s Sputnik V Covid vaccine which were sent to Brazil carried a live version of the common cold virus, Brazil’s health regulator reported.. Angela Rasmussen, a virologist who ...

Health regulators in Brazil say that doses of Russia’s Sputnik V COVID-19 vaccine contain a cold-causing virus capable of replicating in human cells.

05/04/2021 May 4, 2021. Brazil has halted approval of Sputnik V, claiming that a vector virus in the vaccine was not inactive and could cause severe colds. Russia is denying the accusation.

Uniao Quimica is seeking approval for the use of 10 million doses of Sputnik V in Brazil in the first quarter of this year. Russia's RDIF sovereign wealth fund, which is promoting Sputnik globally ...

• The Brazilian state of Bahia has signed a confidentiality agreement on Tuesday to undertake the trials of the Russia’s Sputnik V vaccine and shall receive 500 doses as soon as Anvisa, Brazil ...

The government will not drop Sputnik V from its vaccination program despite being banned by Brazil, where health regulators raised questions about the safety of the Russian-made COVID-19 shot.

On July 3, ahead of the BRICS Summit, Sputnik Brasil gathered prominent experts and journalists from leading Brazilian and ...

Pfizer-BioNTech Vaccine Neutralizes Brazil Variant . The Pfizer-BioNTech coronavirus vaccine appears to be highly effective against a more contagious variant first discovered in Brazil, according to a ...

Russia's Sputnik V COVID-19 vaccine has requested regulatory approval to launch Phase 3 trials in Brazil, Brazilian health regulator Anvisa said late on Tuesday. The Sputnik vaccine is being ...

While Argentina has already started trials to produce the Russian Sputnik V vaccine against covid-19, Brazil’s National Health Surveillance Agency (Anvisa) has filed a petition before the ...

The Brazilian pharmaceutical company that will make Russia's Sputnik V vaccine against COVID-19 expects regulatory approval for Phase III tests by this week or early next at the latest, its Chief ...